U.S. market Closed. Opens in 17 hours 16 minutes

ADCT | ADC Therapeutics SA Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue69.56M209.91M33.92MN/A2.34M1.14M1.80M
Cost of Revenue2.53M4.58M1.39M1.97M107.54MN/AN/A
Gross Profit67.03M205.33M32.52M-1.97M-105.20M1.14MN/A
Operating Expenses233.01M328.96M294.24M219.26M121.74M127.08M93.34M
Selling, General & Admin105.89M141.06M136.24M77.23M13.81M8.60M7.81M
Research & Development127.13M187.90M158.00M142.03M107.54M118.31M85.53M
Other Operating Expenses5.47M14.58M28.49M-46.40M388.00K166.00KN/A
Operating Income-165.99M-123.63M-261.72M-219.26M-119.40M-125.94M-91.67M
Other Expenses / Income-29.43M-31.03M10.21M-26.70M3.50M213.00K1.86M
Before Tax Income-195.42M-154.66M-251.50M-245.96M-115.90M-122.87M-89.81M
Income Tax Expenses39.11M1.14M-21.48M327.00K582.00K224.00K48.00K
Net Income-240.05M-155.80M-230.03M-246.29M-116.48M-123.10M-89.86M
Interest Expenses46.33M36.92M18.34M4.93M156.00K-3.28MN/A
Basic Shares Outstanding81.71M78.15M76.75M65.41M66.87M53.83M58.85M
Diluted Shares Outstanding81.71M78.15M76.75M65.41M66.87M53.83M58.85M
EBITDA-145.78M-98.83M-233.16M-238.27M-113.84M-125.41M-89.47M
EBITDA Margin-209.57%-47.08%-687.46%0.00%-4,865.17%-11,001.23%-4,962.45%
EBIT-154.62M-117.74M-233.16M-241.04M-115.75M-126.15M-89.81M
EBIT Margin-222.29%-56.09%-687.46%0.00%-4,946.41%-11,066.14%-4,981.36%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙